FDA expands approval of implant telescope to those age 65 and older

The U.S. Food and Drug Administration has approved use of VisionCare Ophthalmic Technologies’ implantable miniature telescope in a younger group of patients than was previously approved, according to a company press release. The implant was previously approved for use in patients with end-stage age-related macular degeneration age 75 years and older. The expanded indication includes patients age 65 years and older.

Full Story →